The 39 references in paper P. Cochat, J. Harambat, A.-L. Leclerc, П. Коша, Ж. Харамба, А-Л. Леклерк (2013) “РЕКУРРЕНТНЫЕ ЗАБОЛЕВАНИЯ В ПЕДИАТРИЧЕСКОЙ ПОЧЕЧНОЙ ТРАНСПЛАНТАЦИИ // RECURRENT DISEASES IN PEDIATRIC RENAL TRANSPLANTATION” / spz:neicon:nefr:y:2013:i:3:p:9-16

1
Cochat P, Fargue S, Mestrallet G, et al. Disease recurrence in paediatric renal transplantation. Pediatr Nephrol 2009;
(check this in PDF content)
2
2097-2108 2. Dall’Amico R, Ghiggeri G, Carraro M, et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after transplantation in children. Am J Kidney Dis 1999; 34: 1048-1055
(check this in PDF content)
3
Hickson LJ, Gera M, Amer H, et al. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation 2009; 87: 1232-1239
(check this in PDF content)
4
Kavanagh D, Richards A, Goodship T, Jalanko H. Transplantation in atypical hemolytic uremic syndrome. Semin Thromb Hemost 2010; 36: 653-659
(check this in PDF content)
5
Loirat C, Fremeaux-Bacchi V. Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr Transplant 2008; 12: 619-629
(check this in PDF content)
6
Noris M, Remuzzi G. Thrombotic microangiopathy after kidney transplantation. Am J Tranplant 2010; 10: 1517-1523
(check this in PDF content)
7
Samuel JP, Bell CS, Molony DA, et al. Long-term outcome of renal transplantation patients with Henoch-Schönlein purpura. Clin J Am Soc Nephrol 2011; 6: 2034-2040
(check this in PDF content)
8
Vinai M, Waber P, Seikaly MG. Recurrence of focal segmental glomerulosclerosis in renal allograft: An in-depth review. Pediatr Transplant 2010; 14: 314-325
(check this in PDF content)
9
Fine RN. Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol 2007; 22; 496-502
(check this in PDF content)
10
Stralen KJ, Verrina E, Belingheri M, et al. Graft loss among kidney diseases with a high risk of post-transplant disease recurrence: the size of the problem in pediatric transplantation. Nephrol Dial Transplant (accepted)
(check this in PDF content)
11
Baum M, Ho M, Stablein D, et al. Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis. Pediatr Transplant 2002; 6: 488-492
(check this in PDF content)
12
Saleem MA. The phenomenon of focal segmental glomerulosclerosis post-transplantation – a one-hit wonder? Pediatr Nephrol 2012 (Epub)
(check this in PDF content)
13
Shankland SJ, Pollak MR. A suPAR circulating factor causes kidney disease. Nature Med 2011; 17: 926-927
(check this in PDF content)
14
Wei C, El Hindi S, Li J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nature Med 2011; 17: 952-961
(check this in PDF content)
15
Becker-Cohen R, Bruschi M, Rinat C, et al. Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies. Am J Transplant 2007; 7: 256-260
(check this in PDF content)
16
Mahesh S, Del Rio M, Feuerstein D, et al. Demographics and response to therapeutic plasma exchange in pediatric renal transplantation for focal glomerulosclerosis: a single center experience. Pediatr Transplantation 2008; 12: 682-688
(check this in PDF content)
17
Apeland T, Hartmann A. Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation. Nephrol Dial Transplant 2008; 23: 2091-2094
(check this in PDF content)
18
Grenda R, Jarmużek W, Piatosa B, Rubik J. Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation – Case report. Pediatr Transplantation 2011; 15: e121-125
(check this in PDF content)
19
Hristea D, Hadaya K, Marangon N, et al. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transplant Int
(check this in PDF content)
20
7; 20: 102-105 20. Meyer TN, Thaiss F, Stahl RAK. Immunoadsorption with rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transplant Int 2007; 20: 1066-1071
(check this in PDF content)
21
Okamoto M, Koshino K, Sakai K, et al. A case of recurrent focal segmental glomerulosclerosis involving massive proteinuria (> 50 g/day) immediately after renal transplantation. Clin Transplant 2011; 25: 53-58
(check this in PDF content)
22
Bayrakci US, Baskin E, Sakalli H, et al. Rituximab for post-transplant recurrences of FSGS. Pediatr Transplant 2009; 13: 240-243
(check this in PDF content)
23
Stewart ZA, Shetty R, Nair R, et al. Case report: successful treatment of recurrent focal segmental glomerulosclerosis with a novel rituximab regimen. Transplant Proc 2011; 43: 3994-3996
(check this in PDF content)
24
Cochat P, Ranchin B. Is there a need for a multicenter study to determine the optimal approach to recurrent nephrotic syndrome following renal transplantation? Pediatr Transplantation 2001; 5: 394-397
(check this in PDF content)
25
Couloures K, Pepkowitz SH, Goldfinger D, et al. Preventing recurrence of focal segmental glomerulosclerosis following renal transplantation: a case report. Pediatr Transplant 2006; 10: 962-965
(check this in PDF content)
26
Gonzalez E, Ettenger R, Rianthavorn P, et al. Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation. Pediatr Transplantation 2011; 15: 495-501
(check this in PDF content)
27
Fremeaux-Bacchi V. Treatment of atypical hemolytic uremic syndrome in the era of eculizumab. Clin Kidney J 2012; 5: 4-6
(check this in PDF content)
28
Kwon T, Dragon-Durey MA, Macher MA, et al. Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome. Nephrol Dial Transplant 2008; 23: 2088-2090
(check this in PDF content)
29
Zimmerhackl LB, Besbas N, Jungraithmayr T, et al. Epidemiology, clinical presentation, and pathophysiology of atypical hemolytic uremic syndrome. Semin Thromb Hemost 2006; 32: 113-120
(check this in PDF content)
30
Hirt-Minkowski P, Schaub S, Mayr M, et al. Haemolytic uremic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option? Nephrol Dial Transplant 2009; 24: 3548-3551
(check this in PDF content)
31
Durán CE, Blasco M, Maduell F, Campistol JM. Rescue therapy with eculizumab in a transplant recipient with atypical hemolytic-uremic syndrome. Clin Kidney J 2012; 5: 28-30
(check this in PDF content)
32
Nester C, Stewart Z, Myers D, et al. Pre-emptive eculizumab and plasmapheresis in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2011; 6: 1488-1494
(check this in PDF content)
33
Weitz M, Amon O, Bassler D, et al. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome. Pediatr Nephrol 2011; 26: 1325-1329
(check this in PDF content)
34
Al-Akash SI, Stephen Almond P, Savell Jr VH, et al. Eculizumab induces long-term remission in recurrent post-transplant HUS with C3 gene mutation. Pediatr Nephrol 2011; 26: 613-619
(check this in PDF content)
35
Châtelet V, Lobbedez T, Fremeaux-Bacchi V, et al. Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report. Transplant Proc 2010; 42: 4353-4355
(check this in PDF content)
36
Cochat P, Hulton SA, Acquaviva C, et al. Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant 2012; 27:1729-1736
(check this in PDF content)
37
Ortiz F, Gelpi R, Koskinen P, et al. IgA nephropathy recurs early in the graft when assessed by protocol biopsy. Nephrol Dial Tranplant 2012; 27: 2553-2558
(check this in PDF content)
38
Moroni G, Tandardini F, Gallalli B, et al. The long-term prognosis of renal transplantation in patients with lupus nephritis. Am J Kidney Dis 2005; 45: 903-911
(check this in PDF content)
39
Elmedehem A, Adu D, Savage COS. Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation. Nephrol Dial Transplant 2003; 18: 1001-1004 Поступила в редакцию 17.04.2013 г. Принята в печать 05.06.2013 г.
(check this in PDF content)